Table 2.
Kaplan-Meier survival probability estimates and number at risk at 30, 90, 180, and 365 days by emergency presentation (EP) status, overall and by tumor stage.
| EP-IP |
EP-OP |
NON-EP |
|||||
|---|---|---|---|---|---|---|---|
| Stage | Time (Days) | No.a | Survival probability (95% CI) | No.a | Survival probability (95% CI) | No.a | Survival probability (95% CI) |
|
| |||||||
| Overall | 0 | 201 461 | 1.00 (1.00 to 1.00) | 58 905 | 1.00 (1.00 to 1.00) | 669 012 | 1.00 (1.00 to 1.00) |
| 30 | 157 093 | 0.78 (0.77 to 0.78) | 54 065 | 0.92 (0.91 to 0.92) | 652 976 | 0.98 (0.98 to 0.989) | |
| 90 | 118 682 | 0.59 (0.59 to 0.59) | 47 224 | 0.80 (0.80 to 0.80) | 621 674 | 0.93 (0.92 to 0.93) | |
| 180 | 96 107 | 0.48 (0.47 to 0.48) | 41 923 | 0.71 (0.71 to 0.72) | 589 396 | 0.88 (0.88 to 0.88) | |
| 365 | 72 966 | 0.36 (0.36 to 0.36) | 35 382 | 0.60 (0.60 to 0.60) | 543 408 | 0.81 (0.81 to 0.81) | |
| Distant | 0 | 83 141 | 1.00 (1.00 to 1.00) | 18 055 | 1.00 (1.00 to 1.00) | 97 803 | 1.00 (1.00 to 1.00) |
| 30 | 58 096 | 0.69 (0.69 to 0.70) | 15 244 | 0.84 (0.83 to 0.85) | 89 458 | 0.91 (0.91 to 0.91) | |
| 90 | 36 209 | 0.43 (0.43 to 0.44) | 11 092 | 0.61 (0.60 to 0.62) | 72 765 | 0.74 (0.74 to 0.74) | |
| 180 | 25 080 | 0.30 (0.30 to 0.30) | 8394 | 0.46 (0.46 to 0.47) | 58 289 | 0.60 (0.59 to 0.60) | |
| 365 | 15 037 | 0.18 (0.18 to 0.18) | 5480 | 0.30 (0.30 to 0.31) | 40 544 | 0.41 (0.41 to 0.42) | |
| Regional | 0 | 26 517 | 1.00 (1.00 to 1.00) | 8114 | 1.00 (1.00 to 1.00) | 98 087 | 1.00 (1.00 to 1.00) |
| 30 | 23 133 | 0.87 (0.87 to 0.87) | 7814 | 0.96 (0.96 to 0.97) | 96 890 | 0.99 (0.99 to 0.99) | |
| 90 | 19 720 | 0.74 (0.74 to 0.75) | 7267 | 0.90 (0.89 to 0.90) | 93 900 | 0.96 (0.96 to 0.96) | |
| 180 | 17 097 | 0.64 (0.64 to 0.65) | 6619 | 0.82 (0.81 to 0.82) | 89 769 | 0.92 (0.91 to 0.92) | |
| 365 | 13 831 | 0.52 (0.52 to 0.53) | 5699 | 0.70 (0.69 to 0.71) | 82 710 | 0.84 (0.84 to 0.85) | |
| Localized | 0 | 35 317 | 1.00 (1.00 to 1.00) | 18 770 | 1.00 (1.00 to 1.00) | 338 408 | 1.00 (1.00 to 1.00) |
| 30 | 31 933 | 0.90 (0.90 to 0.91) | 18 440 | 0.98 (0.98 to 0.98) | 336 857 | 1.00 (1.00 to 1.00) | |
| 90 | 28 433 | 0.80 (0.80 to 0.81) | 17 848 | 0.95 (0.95 to 0.95) | 333 519 | 0.99 (0.99 to 0.99) | |
| 180 | 25 627 | 0.73 (0.72 to 0.73) | 17 149 | 0.91 (0.91 to 0.92) | 328 952 | 0.97 (0.97 to 0.97) | |
| 365 | 22 197 | 0.63 (0.62 to 0.63) | 16 023 | 0.85 (0.85 to 0.86) | 319 997 | 0.95 (0.95 to 0.95) | |
| Unstaged | 0 | 14 253 | 1.00 (1.00 to 1.00) | 3587 | 1.00 (1.00 to 1.00) | 35 640 | 1.00 (1.00 to 1.00) |
| 30 | 9613 | 0.67 (0.66 to 0.68) | 2869 | 0.79 (0.78 to 0.81) | 33 162 | 0.93 (0.93 to 0.93) | |
| 90 | 6461 | 0.45 (0.44 to 0.46) | 2259 | 0.63 (0.61 to 0.64) | 29 561 | 0.83 (0.82 to 0.83) | |
| 180 | 4685 | 0.33 (0.32 to 0.34) | 1806 | 0.50 (0.49 to 0.52) | 25 889 | 0.73 (0.72 to 0.73) | |
| 365 | 3086 | 0.22 (0.21 to 0.22) | 1383 | 0.39 (0.37 to 0.40) | 21 994 | 0.62 (0.61 to 0.62) | |
| Hematological cancers (not staged) | 0 | 29 777 | 1.00 (1.00 to 1.00) | 7172 | 1.00 (1.00 to 1.00) | 70 875 | 1.00 (1.00 to 1.00) |
| 30 | 23 293 | 0.78 (0.77 to 0.78) | 6581 | 0.92 (0.91 to 0.92) | 68 897 | 0.97 (0.97 to 0.97) | |
| 90 | 18 378 | 0.62 (0.61 to 0.62) | 5916 | 0.82 (0.82 to 0.83) | 65 546 | 0.92 (0.92 to 0.93) | |
| 180 | 15 477 | 0.52 (0.51 to 0.53) | 5404 | 0.75 (0.74 to 0.76) | 62 130 | 0.88 (0.87 to 0.88) | |
| 365 | 12 560 | 0.42 (0.42 to 0.43) | 4776 | 0.67 (0.66 to 0.68) | 57 536 | 0.81 (0.81 to 0.81) | |
a
This represents number of people at risk at each time point. Participants were followed for at least 1year, so there was no censoring in the data, and number of death events could be calculated based on the difference in number of people at risk between any 2 time points.